Single-use Bioprocessing Systems Market Trends, Applications, Competitive Landscape and Regional Insights to 2028

Wilmington, Delaware, United States, Transparency Market Research Inc.: Single-use systems are biopharmaceutical manufacturing equipment that are designed to be utilized once and then disposed off.

Wilmington, Delaware, United States, Transparency Market Research Inc.: Single-use systems are biopharmaceutical manufacturing (bioprocessing) equipment that are designed to be utilized once and then disposed off. Usually, single-use systems equipment is made of plastic components that have been sterilized and sealed utilizing gamma irradiation. The global single-use bioprocessing systems market is likely to observe growth due to rising demand for biologics.

Flexibility and Speed of the Product to Bolster its Demand in the Near Future

The global single-use bioprocessing systems market is likely to be driven by the increasing expiry of patents of blockbuster molecules and rising demand for biologics. In addition, there are a limited number of potential products in the pipeline is further predicted to pave way for steady growth of the global single-use bioprocessing systems market. Novel technologies like single-use bioprocessing come with quick turnaround of products and are cost-effective. The benefits of single use bioprocessing systems are as mentioned below

Diminished chances of cross contamination

  • Cost reduction
  • Hassle-free disposal
  • Reduced demand for energy and water
  • Increase in productivity
  • Time savings

Request Sample of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3753

Single-use technology has emerged as a prominent one in the pre-commercial manufacturing, comprising both clinical and preclinical scale. In the last few years, there has been a rapid rise in the adoption of single-use technology-based process lines. Such is the adoption rate, that this technology has even exerted dominance over pre-commercial biopharmaceutical manufacturing. In most of the bioprocessing set ups, a considerable amount of disposable products are used, which add to the revenue of the global single-use bioprocessing systems market in the years to come.

While keeping the total operational cost to the minimum, the speed and flexibility of single use products has further augmented the adoption of the Single-use technology-based process lines. In addition, with the advent of intelligent biomanufacturing and automation, the effectiveness of these processes has been increased rapidly. With the rising technological progress, single-use bioprocessing model is expected to witness augmented expansion.

Market and Report Description

Single-use bioprocessing systems are disposable equipment and consumables used in research & development as well as commercial production of biologics and metabolites. Adoption of single-use bioprocessing systems has seen a paradigm shift in recent years compared to its market over a decade ago.

Single-use bioprocessing systems include bioreactors & fermenters, mixers, bags, bioprocess containers, filtration devices, tubing, sampling systems, connectors & clamps, and probes & sensors

Single-use bioprocessing systems are majorly used to prevent hospital acquired infection. Single-use bioprocessing systems permit biopharmaceutical organizations to conduct speedy R&D and pilot studies, with the added benefit of lowered capital costs.

Request for Report Methodology - https://www.transparencymarketresearch.com/sample/sample.php?flag=RRM&rep_id=3753

Market Drivers: Overview

Growing acceptance of single-use technologies in manufacturing processes and technological advancements drives the single-use bioprocessing systems market

Ability of customers to make changes and order single-use product as per their own customization also drives the single-use bioprocessing systems market. Bioreactors and single-use bags and containers are all open to customer specific requirements, depending on type of application.

Number of therapeutic antibody candidates in phase 3 clinical development in the U.S. has risen to over 50 in the past five years, almost double of what it was back then. Single-use technologies are being rapidly adopted in these application areas. Hence, growth in monoclonal antibody production and vaccine production is anticipated to drive the single-use bioprocessing systems market.

Global increase in ageing population is also major factor for increase in growth of single-use bioprocessing systems market. According to the 2016s research findings by the World Health Organization (WHO), people aged 60 and above will approximately reach 2.5 billion by end of 2050. The aging population is more prone to diseases such as hypertension, chronic kidney diseases diabetes, cardiovascular diseases, and cancer as they have less immunity. Such factors are likely to drive the growth of single-use bioprocessing systems market

Ask for References - https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=3753

Market Segmentation: Global Single-use Bioprocessing Systems Market

Based on product, the global single-use bioprocessing systems market has been divided into bioreactors & fermenters, mixers, bags, bioprocess containers, filtration devices, tubing, sampling systems, connectors & clamps, and probes & sensors

In terms of application, the global single-use bioprocessing systems market has been classified into monoclonal antibody production, vaccine production, plant cell cultivation, patient specific cell therapies, and others

In terms of end-user, the global single-use bioprocessing systems market has been categorized into pharmaceutical companies, biotechnology companies, CROs & CMOs, and academic & research institutes

Each of the segments has been analyzed in detail for market trends, recent trends, and developments, drivers, restraints, opportunities, and useful insights. The report provides current and future revenue (US$ Mn) for each of these segments from 2018 to 2028, considering 2019 as the base year. The compound annual growth rate (% CAGR) has been provided for each segment and market from 2020 to 2028 along with market size estimations.

Make an Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=3753

Geographic Overview: Global Single-use Bioprocessing Systems Market

In terms of region, the global single-use bioprocessing systems market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Regions have been divided into major countries and sub-regions.

The current and future market values in terms of revenue (US$ Mn) of these regional markets and their major countries have been provided in the report from 2018 to 2028, with their CAGRs from 2020 to 2028

The study also offers a list of recommendations, highlights, and useful insights of the market which would help new companies willing to enter the market and existing companies to increase market shares, and help in the decision-making process.

Major Players

The report concludes with the company profiles section that includes key information about major players in the market

Leading players analyzed in the report include

  • Danaher Corporation
  • Eppendorf AG
  • Meissner Filtration Products, Inc.
  • Parker Hannifin Corporation
  • PBS Biotech, Inc
  • Thermo Fisher Scientific, Inc
  • GE Healthcare (General Electric Company)
  • Merck KGaA
  • Saint-Gobain
  • Sartorius AG.

Each of these players has been profiled in the report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

More Trending Reports by Transparency Market Research –

Diagnostic Specialty Antibodies Market: The global diagnostic specialty antibody market was valued at US$ 22.6 Bn in 2018 and is anticipated to expand at a CAGR of 5.3% from 2019 to 2027.

Biotherapeutics Cell Line Development Market: The global biotherapeutics cell line development market is expected to reach ~US$ 224 Mn by 2030.

Genome Engineering Market: The global genome engineering market was valued at US$ 3,685.4 Mn in 2018 and is anticipated to expand at a CAGR of 10.9% from 2019 to 2027.

Metagenomics Market: The global metagenomics market was valued at US$ 1.3 Bn in 2019. It is projected to expand at a high CAGR from 2020 to 2030.

Oligonucleotide Synthesis Market: The global oligonucleotide synthesis market was valued at US$ 1,966.2 Mn in 2018 and is anticipated to expand at a CAGR of 9.5% from 2019 to 2027.

API Market: The global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) market is expected to attain a market value of US$ 4.7 Bn by the end of 2030.

Genetic Testing Services Market: The global genetic testing services market was valued at US$ 41.2 Bn in 2018 and is anticipated to expand at a CAGR of 7.3% from 2019 to 2027.

Non-Invasive Prenatal Testing Market: The non-invasive prenatal testing market is likely to develop at a CAGR of 16.4% during the forecast period, from 2019 to 2027.

About Us

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com